Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Shareholders Equity (Quarterly): 159.33M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 159.33M |
| September 30, 2023 | 172.42M |
| June 30, 2023 | 197.62M |
| March 31, 2023 | 222.76M |
| December 31, 2022 | 223.47M |
| September 30, 2022 | 248.34M |
| June 30, 2022 | 273.73M |
| March 31, 2022 | 295.82M |
| Date | Value |
|---|---|
| December 31, 2021 | 319.48M |
| September 30, 2021 | 341.03M |
| June 30, 2021 | 361.34M |
| March 31, 2021 | 378.57M |
| December 31, 2020 | 393.27M |
| September 30, 2020 | 152.50M |
| December 31, 2019 | -17.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-17.49M
Minimum
Dec 2019
393.27M
Maximum
Dec 2020
248.15M
Average
248.34M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| XOMA Corp | 88.72M |
| Societal CDMO Inc (DELISTED) | 58.66M |
| NGM Biopharmaceuticals Inc (DELISTED) | 148.64M |
| Avrobio Inc | 94.74M |
| Landos Biopharma Inc | 31.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 173.60M |
| Total Liabilities (Quarterly) | 14.28M |